VPL Chemicals – A Symbio Group Company
Trusted API Manufacturer with Global Reach
VPL Chemicals, a 100% Symbio-owned company, stands as a cornerstone of Symbio’s manufacturing ecosystem - combining scientific depth, regulatory excellence, and operational agility. Located near Bangalore, the ANVISA- and WHO-GMP–approved facility exemplifies Symbio’s commitment to world-class quality, sustainability, and continuous innovation. With Certificates of Suitability (CEPs/COPPs), VPL is aligned with stringent global standards and serves as a trusted manufacturing partner to leading pharmaceutical companies worldwide.
Expertise in APIs and Value-Added Pellets & Granules
At its core, VPL specializes in the manufacture of high-quality Active Pharmaceutical Ingredients (APIs) across a diverse therapeutic spectrum, backed by strong process chemistry and a deep focus on green and efficient manufacturing. Complementing its API capabilities, VPL also houses a dedicated facility for pre-formulated bulk products (pellets and granules). These ready-to-use formats, available for most of our pharmaceutical enzymes and select APIs, enable partners to directly compress tablets or fill capsules, saving valuable development time, formulation effort, and ultimately cost. The facility is equally equipped to take on customized development projects, providing tailored solutions that add strategic value to every collaboration.
Global Presence and Regulatory Excellence
VPL’s manufacturing excellence extends across major markets, with exports to Germany, Spain, Portugal, Brazil, Mexico, Australia, South Korea, Turkey, and Russia, among others. Its reputation for reliability, regulatory strength, and science-led execution has made VPL a preferred partner for both regulated and emerging markets. As part of Symbio’s broader vision, VPL continues to push the boundaries of API and pre-formulated bulk options - building chemistry that connects global healthcare needs with sustainable, high-quality solutions.
Symbio – Vizag Manufacturing Facility (Need to add photos)
Flagship Facility for Advanced API and CDMO Manufacturing
Symbio’s flagship manufacturing facility in Visakhapatnam (Vizag) stands as the embodiment of our vision to create globally benchmarked, future-ready infrastructure. Purpose-built to meet the world’s most stringent regulatory standards, the site is already WHO-GMP certified and USFDA/EUGMP audits awaited, with design and operating systems aligned to the expectations of stringent regulated markets.
Designed for Scale, Built for Precision
Spanning six acres with a capacity scalable to over 600 KL, the Vizag facility combines flexibility with scientific rigor. Equipped with cleanroom environments, multiple reaction suites, and advanced containment systems, it can seamlessly handle both small-volume, high-value molecules and large-scale commercial APIs. The site integrates green chemistry, solvent recovery, and process optimization frameworks, reflecting Symbio’s commitment to sustainable and efficient manufacturing.
CDMO-Ready Platform for Global Partnerships
Beyond its API strength, Vizag is at the heart of Symbio’s expanding CDMO platform - offering specialized infrastructure for advanced intermediates, and complex chemistry projects. The facility supports custom synthesis, process development, scale-up, and technology transfer for both regulated and emerging markets, enabling partners to shorten development timelines and achieve commercial viability with confidence.
Commitment to Quality, Compliance, and Collaboration
At Vizag, quality is engineered into every process. A dedicated QA and regulatory team ensures end-to-end compliance, while advanced digital monitoring systems enable real-time control and traceability. Backed by a team of seasoned scientists and manufacturing experts, Symbio’s Vizag facility represents the intersection of science, scale, and partnership - a trusted global platform designed to bring chemistry to life, responsibly and at scale.
Symbio – Tumkur Facility
Specialized Enzyme-Based API and Intermediate Manufacturing
Spread across five acres, the GMP-compliant Tumkur facility focuses on the production of enzyme-based APIs, and intermediates, and complex biocatalytic processes. Its infrastructure supports the commercial production of pharmaceutical enzymes.
Quality Systems/ Quality Control
In our manufacturing facilities, the underlying principle of product manufacturing is based on the concept of quality by design. The key aspects such as vendor management, critical control measures which are essential for robust manufacturing is monitored by competent and experienced professional team. The in-house lab is adequately equipped to perform routine tests for release of KSM, RM, in-process and finished product as per the pharmacopeial standards. The overall GWP, GMP & GLP environment allows us to produce and deliver quality goods to our esteemed customers.For our trading business, the QA team ensures Good Warehouse Practise (GWP) for material management, storage and distribution at our dedicated warehouse located at Chennai in accordance with the Drugs Control Department guidelines and in-house Standard Operating Procedures. Our QMS (Quality Management Systems) meets the requirement of ISO 9001:2015 certification.
The QC & QA team regularly visit Contract Manufacturing Units (CMUs) for process & product documentation review. QC teams also visit customers laboratories for analytical method demonstration/method transfer activities. We engage with various NABL-accredited, well-equipped reputed laboratories for performing speciality tests so that we can meet the additional customer specifications.
Regulatory Compliance
We understand the regulatory requirements for registration of Drug Substances with Central Drugs Standard Control Organization (CDSCO) - National Regulatory Authority of India. We have successfully registered over 20 APIs offered by various world-class manufacturers with USFDA/EUGMP certifications.We also offer Drug Master Files (DMFs) of speciality APIs from our CMUs as well as own-sites. Our APIs are registered in various geographies comprising of South America, CIS, SE Asia and Middle East.
It has been our constant endeavour to work with Global pharma Companies & Emerging pharma Companies in India and International markets to meet their expectations on products and services.
Certifications
Form 10
Download our Form 10: